Artificial intelligence (AI) software developer Lunit has received clearance from the Health Sciences Authority (HSA) in Singapore for its Insight CXR and Insight MMG AI software applications.
CXR detects lesions on chest x-rays that are suspicious of chest abnormalities, while MMG spots suspicious lesions on mammograms, according to the vendor. Lunit said that Fem Surgery in Singapore has already begun using MMG in clinical practice for breast cancer screening.
